Walleye Trading
LGND icon

Walleye Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Walleye Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,200
Closed -$236K – 4411
2024
Q4 		$236K Buy
+2,200
New +$249K ﹤0.01% 3141
2024
Q2 		– Sell
-4,000
Closed -$292K – 4634
2024
Q1 		$292K Hold
4,000
– – ﹤0.01% 3197
2023
Q4 		$286K Sell
4,000
-10,100
-72% -$596K ﹤0.01% 3528
2023
Q3 		$845K Buy
+14,100
New +$928K ﹤0.01% 2512
2022
Q2 		– Sell
-1,924
Closed -$135K – 5426
2022
Q1 		$135K Sell
1,924
-7,534
-80% -$547K ﹤0.01% 4085
2021
Q4 		$911K Buy
9,458
+3,847
+69% +$355K ﹤0.01% 2317
2021
Q3 		$488K Buy
+5,611
New +$434K ﹤0.01% 2946
2021
Q2 		– Sell
-9,458
Closed -$899K – 5369
2021
Q1 		$899K Buy
+9,458
New +$894K ﹤0.01% 2020
2020
Q3 		– Sell
-2,565
Closed -$179K – 4402
2020
Q2 		$179K Buy
+2,565
New +$163K ﹤0.01% 3150
2020
Q1 		– Sell
-25,969
Closed -$1.69M – 4292
2019
Q4 		$1.69M Buy
25,969
+9,939
+62% +$664K 0.01% 1348
2019
Q3 		$995K Sell
16,030
-24,366
-60% -$1.53M 0.01% 1606
2019
Q2 		$2.88M Buy
40,396
+37,671
+1,382% +$2.77M 0.02% 787
2019
Q1 		$214K Buy
2,725
+801
+42% +$60.7K ﹤0.01% 2971
2018
Q4 		$163K Sell
1,924
-10,900
-85% -$1.16M ﹤0.01% 3577
2018
Q3 		$2.2M Sell
12,824
-1,603
-11% -$242K 0.01% 1231
2018
Q2 		$1.86M Buy
+14,427
New +$1.61M 0.01% 1428

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's LGND Position: Q4 2023 in Review

Walleye Trading sold out of Ligand Pharmaceuticals (LGND) in Q4 2023, closing a stake of 132 shares — an estimated $7.79K sold.

Walleye Trading first reported a position in LGND in Q2 2015 and held it in 4 quarters. The position peaked at $260K in Q1 2022. 211 funds tracked by Wall St. Rank hold LGND as of Q4 2023.

  • Walleye Trading reported no remaining Ligand Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 132 Ligand Pharmaceuticals shares in Q4 2023, an estimated $7.79K.
  • Walleye Trading first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Walleye Trading's Ligand Pharmaceuticals position peaked at $260K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.